Evidence map›Paper›PMID 41781491›Full record

ArticleExperimental & molecular medicine2026

Uncovering the acetylation sites of Dnmt3L that regulate protein stability and differentiation potency in embryonic stem cells.

Yun Ji Nam, Hyungu Kwon, Hyun Jun Im, Naimur Rahman, Humaira Lubna, Siwon Lee, Hee-Sung Ahn, Gayoung Jang, YongHwan Kim, Hyein Ju and 11 more

Abstract read
In one paragraph

Article in Experimental & molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Yun Ji Nam *Department of Cell and Genetic Engineering, Brain Korea 21 Project, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Hyungu Kwon *Department of Cell and Genetic Engineering, Brain Korea 21 Project, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Hyun Jun ImDepartment of Cell and Genetic Engineering, Brain Korea 21 Project, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Naimur RahmanDepartment of Microbiology and Immunology, Chonnam National University Medical School, Hwasun-gun, Republic of Korea.
Humaira LubnaDepartment of Microbiology and Immunology, Chonnam National University Medical School, Hwasun-gun, Republic of Korea.
Siwon LeeDepartment of Cell and Genetic Engineering, Brain Korea 21 Project, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Hee-Sung AhnDepartment of Convergence Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.ORCID http://orcid.org/0000-0003-2241-6536
Gayoung JangDepartment of Cell and Genetic Engineering, Brain Korea 21 Project, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
YongHwan KimDepartment of Cell and Genetic Engineering, Brain Korea 21 Project, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.ORCID http://orcid.org/0000-0003-0621-5937
Hyein JuDepartment of Cell and Genetic Engineering, Brain Korea 21 Project, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Seok Woo HaDepartment of Cell and Genetic Engineering, Brain Korea 21 Project, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Hyun Ji KimDepartment of Cell and Genetic Engineering, Brain Korea 21 Project, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Dabin LeeDepartment of Cell and Genetic Engineering, Brain Korea 21 Project, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Sang Jin ParkDepartment of Cell and Genetic Engineering, Brain Korea 21 Project, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Sang Hoon SongDepartment of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Juhyun ParkDepartment of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Yongsub KimDepartment of Cell and Genetic Engineering, Brain Korea 21 Project, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Yoonjoo ChoiDepartment of Microbiology and Immunology, Chonnam National University Medical School, Hwasun-gun, Republic of Korea.
Kyunggon KimDepartment of Medical Informatics and Biostatistics, Brain Korea 21 Project, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea. kimkyunggon@gmail.com.ORCID http://orcid.org/0000-0002-3072-5331
Dong-Myung ShinDepartment of Cell and Genetic Engineering, Brain Korea 21 Project, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea. d0shin03@amc.seoul.kr.ORCID http://orcid.org/0000-0002-0511-5750
Seungun LeeDepartment of Cell and Genetic Engineering, Brain Korea 21 Project, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea. naiad0226@ulsan.ac.kr.ORCID http://orcid.org/0000-0001-5041-5368

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The epigenetic status, which regulates the cellular identity and differentiation potential of pluripotent stem (PS) cells, dynamically responds to the culture environment, affecting the safe and effective use of PS cells for basic research and therapeutic applications. However, the key mediator(s) representing the epigenetic signatures of PS cells under distinct culture conditions remains unclear. Here we investigated the role of DNA methyltransferase 3-like (Dnmt3L) in modulation of the DNA methylation and differentiation potential of mouse embryonic stem (ES) cells. Unlike other de novo DNA methyltransferases, Dnmt3L exhibited a uniquely dynamic expression pattern during prolonged 2i-leukemia inhibitory factor culture, which was marked by rapid post-transcriptional upregulation that sensitively reflected changes in the extracellular environment. Mass spectrometry identified that acetylation of lysine residues K238 and K412 controlled Dnmt3L protein stability. This site-specific acetylation critically modulated expression of genes associated with naive pluripotency and lineage differentiation-especially toward germline, neural and cardiac fates-through targeted DNA methylation and thereby orchestrated the lineage-specific developmental potential of mouse ES cells both in vitro and in vivo. Our findings demonstrate that Dnmt3L is a key regulator of epigenetic stability at developmentally critical loci in mouse ES cells and dynamically responds to changes in the extracellular culture environment. Thus, elucidation of the regulatory mechanism of Dnmt3L may provide insight into the onset of epigenetic aberrations and suggest the optimal culture conditions to preserve the epigenetic integrity of ES cells, which has significant implications for regenerative medicine.

Indexed as

Cell DifferentiationDNA (Cytosine-5-)-MethyltransferasesEmbryonic Stem CellsMouse Embryonic Stem CellsAcetylationAnimalsDNA MethylationEpigenesis, GeneticMiceProtein Processing, Post-TranslationalProtein StabilityDNA (Cytosine-5-)-MethyltransferasesDnmt3l protein, mouse

Identifiers

PMID41781491
PMCPMC13049025

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.